LH/Mav |
plasma total cholesterol level |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood cholesterol amount |
male |
112 days
| 14 |
|
|
116.22 |
mg/dl |
4.25 |
15.89 |
plasma total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
102753 |
2721 |
LL/Mav |
plasma triglyceride level |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood triglyceride amount |
male |
112 days
| 18 |
|
|
1.46 |
mmol/l |
0.08 |
0.34 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
102755 |
2721 |
LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
aorta mass |
male |
112 days
| 14 |
|
|
13.1 |
mg/100g |
0.1 |
0.37 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102773 |
2721 |
LH/Mav |
creatinine clearance |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
glomerular filtration trait |
male |
112 days
| 14 |
|
|
1.4 |
ml/min |
0.05 |
0.19 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102777 |
2721 |
SD |
glomerular filtration rate to body weight ratio |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.67 |
ml/min/100g |
0.02 |
0.06 |
inulin analysis by thiourea-resorcinol assay |
|
0.0 |
stz |
154 |
days |
|
|
99902 |
2358 |
SD |
glomerular filtration rate to body weight ratio |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.68 |
ml/min/100g |
0.02 |
0.06 |
inulin analysis by thiourea-resorcinol assay |
|
0.0 |
stz |
154 |
days |
|
|
99903 |
2358 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 17 |
|
|
0.5 |
ml/min/100g |
0.03 |
0.12 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99981 |
2378 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 16 |
|
|
44.5 |
% |
0.6 |
2.4 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
99979 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 17 |
|
|
3.3 |
ml/min/100g |
0.11 |
0.45 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99992 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 16 |
|
|
7.1 |
mmHg/ml/min |
0.3 |
1.2 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99998 |
2378 |
MHS |
urine sodium excretion rate |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
urine sodium amount |
male |
213 days
| 6 |
|
|
0.81 |
mEq/d |
0.1 |
0.25 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
104031 |
2886 |
MNS |
urine sodium excretion rate |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
urine sodium amount |
male |
213 days
| 9 |
|
|
2.07 |
mEq/d |
0.45 |
1.36 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
104032 |
2886 |
MNS |
urine potassium excretion rate |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
urine potassium amount |
male |
213 days
| 9 |
|
|
3.52 |
mEq/d |
0.68 |
2.04 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
104034 |
2886 |
LH/Mav |
plasma triglyceride level |
streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood triglyceride amount |
male |
112 days
| 10 |
|
|
2.42 |
mmol/l |
0.3 |
0.95 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
102671 |
2703 |
LH/Mav |
both kidneys wet weight to body weight ratio |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
kidney mass |
male |
112 days
| 7 |
|
|
8.05 |
g/kg |
0.24 |
0.63 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102697 |
2703 |
LH/Mav |
timed urine volume |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
urine output |
male |
49 days-56 days |
37 |
|
|
12.6 |
ml/d |
0.7 |
4.26 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
102649 |
2703 |
WKY |
body weight |
streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
body mass |
male |
156 days
| 10 |
|
|
261.43 |
g |
21.34 |
67.48 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
99109 |
2219 |
WKY |
single kidney wet weight to body weight ratio |
streptozotocin (60 mg/kg) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
kidney mass |
male |
156 days
| 10 |
|
|
5.47 |
g/kg |
0.46 |
1.45 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
99114 |
2219 |
WKY |
single kidney wet weight to body weight ratio |
streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
kidney mass |
male |
156 days
| 10 |
|
|
4.46 |
g/kg |
0.42 |
1.33 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
99116 |
2219 |
WKY |
body weight |
streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
body mass |
male |
156 days
| 10 |
|
|
295.56 |
g |
21.89 |
69.22 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
99110 |
2219 |
WKY |
single kidney wet weight to body weight ratio |
streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
kidney mass |
male |
156 days
| 10 |
|
|
5.42 |
g/kg |
0.51 |
1.61 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
99115 |
2219 |
WKY |
timed urine volume |
streptozotocin (60 mg/kg) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156 days
| 10 |
|
|
140.19 |
ml/d |
10.38 |
32.82 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
99120 |
2219 |
SD |
left kidney wet weight |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney mass |
male |
0 days
| 8 |
|
|
1.94 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0.0 |
stz |
154 |
days |
|
|
99893 |
2358 |
Crl:SD |
kidney glomerulus volume |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
kidney glomerulus morphology trait |
male |
364 days
| 6 |
|
|
2.18 |
x 10E6 um3 |
0.11 |
0.27 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
308 |
days |
|
|
100773 |
2522 |
SD |
body weight |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
|
|
570.0 |
g |
31.47 |
89.0 |
body weighing method |
|
0.0 |
stz |
224 |
days |
|
|
99915 |
2358 |
SD |
renal filtration fraction |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.29 |
null |
0.01 |
0.02 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
stz |
154 |
days |
GFR by inulin method |
|
99912 |
2358 |
SD |
systolic blood pressure |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
|
150.0 |
mmHg |
1.41 |
4.0 |
tail cuff plethysmography |
|
0.0 |
stz |
224 |
days |
|
|
99923 |
2358 |
SD |
renal filtration fraction |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.29 |
null |
0.0 |
0.01 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
stz |
224 |
days |
GFR by inulin method |
|
99932 |
2358 |
SD |
effective renal plasma flow |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
|
2.27 |
ml/min/100g |
0.06 |
0.18 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
stz |
224 |
days |
|
|
99930 |
2358 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 8 |
|
|
357.0 |
mg/dl |
11.0 |
31.11 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
99943 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 6 |
|
|
0.5 |
ml/min/100g |
0.02 |
0.06 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99949 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
|
3.09 |
ml/min/100g |
0.18 |
0.51 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99951 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
|
2.32 |
ml/min/100g |
0.11 |
0.31 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99953 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
|
8.8 |
mmHg/ml/min |
0.5 |
1.41 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99962 |
2378 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then enalapril (15 mg/l) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
|
|
179.66 |
null |
2.47 |
6.05 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
371 |
days |
|
|
100791 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then enalapril (15 mg/l) (for 63 days) and anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
|
|
201.84 |
null |
11.34 |
27.78 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
371 |
days |
|
|
100792 |
2522 |
MNS |
artery inner diameter |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
12.0 |
um |
|
5.6 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104147 |
2907 |
MHS |
artery lumen to artery total diameter ratio |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
36.9 |
% |
|
9.0 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104153 |
2907 |
MNS |
body weight |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
168 days
| 8 |
|
|
370.0 |
g |
13.79 |
39.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104065 |
2907 |
MHS |
body weight |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
168 days
| 9 |
|
|
364.0 |
g |
13.67 |
41.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104067 |
2907 |
Crl:WI |
body weight |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
252 days
| 14 |
|
|
354.0 |
g |
10.69 |
40.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104073 |
2907 |
MNS |
mean arterial blood pressure |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
arterial blood pressure trait |
male |
168 days
| 6 |
|
|
94.8 |
mmHg |
2.08 |
5.1 |
vascular fluid filled catheter |
trunk of common carotid artery |
0.0 |
|
0 |
|
|
|
104103 |
2907 |
MNS |
glomerular filtration rate |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
glomerular filtration trait |
male |
126 days
| 6 |
|
|
4.1 |
ml/min |
0.13 |
0.33 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104115 |
2907 |
MHS |
renal plasma flow (inulin) |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney plasma flow trait |
male |
126 days
| 6 |
|
|
13.66 |
ml/min |
0.62 |
1.51 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104125 |
2907 |
SBH/Ygl |
systolic blood pressure |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
arterial blood pressure trait |
male |
98 days
| 7 |
|
|
181.0 |
mmHg |
2.0 |
5.29 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
106699 |
3038 |
SBH/Ygl |
body weight |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
body mass |
male |
98 days
| 7 |
|
|
223.0 |
g |
15.0 |
39.69 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
106702 |
3038 |
SBH/Ygl |
heart weight |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart mass |
male |
98 days
| 7 |
|
|
1.07 |
g |
0.07 |
0.18 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
106710 |
3038 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 16 |
|
|
11.1 |
x 10E3 um2 |
2.8 |
11.2 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
107513 |
2378 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 17 |
|
|
3.2 |
g/kg |
0.1 |
0.41 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
107452 |
2378 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 16 |
|
|
267.0 |
g |
9.0 |
36.0 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
107449 |
2378 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 16 |
|
|
8.1 |
mg/g |
0.2 |
0.8 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
107458 |
2378 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 17 |
|
|
11.8 |
x 10E3 um2 |
2.9 |
11.96 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
107512 |
2378 |
MNS |
glomerular filtration rate |
streptozotocin (50 mg/kg) (for 147 days) and insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
glomerular filtration trait |
male |
213 days
| 9 |
|
|
0.0 |
ml/min |
0.0 |
0.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104028 |
2886 |
LL/Mav |
plasma total cholesterol level |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood cholesterol amount |
male |
112 days
| 18 |
|
|
52.9 |
mg/dl |
1.54 |
6.55 |
plasma total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
102751 |
2721 |
LH/Mav |
both kidneys wet weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
kidney mass |
male |
112 days
| 14 |
|
|
6.65 |
g/kg |
0.08 |
0.3 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102765 |
2721 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 16 |
|
|
0.22 |
null |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99988 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 17 |
|
|
1.72 |
ml/min/100g |
0.11 |
0.45 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99991 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 16 |
|
|
6.8 |
mmHg/ml/min |
0.3 |
1.2 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99999 |
2378 |
LH/Mav |
plasma total cholesterol level |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood cholesterol amount |
male |
112 days
| 7 |
|
|
110.81 |
mg/dl |
4.25 |
11.24 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
102667 |
2703 |
LH/Mav |
plasma creatinine level |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood creatinine amount |
male |
112 days
| 7 |
|
|
0.59 |
mg/dl |
0.02 |
0.04 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102679 |
2703 |
LH/Mav |
plasma triglyceride level |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood triglyceride amount |
male |
112 days
| 7 |
|
|
1.58 |
mmol/l |
0.08 |
0.21 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
102673 |
2703 |
LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112 days
| 11 |
|
|
10.1 |
mg/100g |
0.2 |
0.66 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102690 |
2703 |
LH/Mav |
both kidneys wet weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
kidney mass |
male |
112 days
| 9 |
|
|
7.02 |
g/kg |
0.18 |
0.54 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102695 |
2703 |
SD |
left kidney wet weight |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney mass |
male |
0 days
| 8 |
|
|
1.9 |
g |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
stz |
154 |
days |
|
|
99894 |
2358 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
|
2.33 |
ml/min/100g |
0.09 |
0.25 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99952 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.79 |
ml/min/100g |
0.03 |
0.08 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99946 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.54 |
ml/min/100g |
0.02 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99948 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.26 |
null |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99956 |
2378 |
LL/Mav |
body weight |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
body mass |
male |
56 days
| 18 |
|
|
215.0 |
g |
3.0 |
12.73 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
102699 |
2721 |
LH/Mav |
body weight |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
body mass |
male |
112 days
| 14 |
|
|
388.0 |
g |
5.0 |
18.71 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
102725 |
2721 |
LH/Mav |
systolic blood pressure |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
arterial blood pressure trait |
male |
112 days
| 14 |
mean of 3 samples of undefined duration |
serial mean |
179.0 |
mmHg |
4.0 |
14.97 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
102729 |
2721 |
LL/Mav |
timed urine volume |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
112 days
| 18 |
|
|
10.8 |
ml/d |
0.3 |
1.27 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
102731 |
2721 |
LH/Mav |
urine total protein excretion rate |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
total urine protein amount |
male |
112 days
| 14 |
|
|
184.0 |
mg/d |
11.0 |
41.16 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
102737 |
2721 |
LH/Mav |
urine creatinine excretion rate |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine creatinine amount |
male |
112 days
| 14 |
|
|
13.3 |
mg/d |
0.2 |
0.75 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102749 |
2721 |
LL/Mav |
plasma creatinine level |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood creatinine amount |
male |
112 days
| 18 |
|
|
0.5 |
mg/dl |
0.01 |
0.03 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102759 |
2721 |
LL/Mav |
both kidneys wet weight to body weight ratio |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
kidney mass |
male |
112 days
| 18 |
|
|
6.61 |
g/kg |
0.08 |
0.34 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102763 |
2721 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
heart left ventricle mass |
male |
112 days
| 14 |
|
|
2.25 |
mg/g |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102769 |
2721 |
WKY |
timed urine volume |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156 days
| 10 |
|
|
53.91 |
ml/d |
7.67 |
24.25 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
99124 |
2219 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 16 |
|
|
317.0 |
mg/dl |
19.0 |
76.0 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
99974 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 17 |
|
|
41.47 |
ml/d |
4.46 |
18.41 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
100002 |
2378 |
MHS |
timed urine volume |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
urine output |
male |
213 days
| 6 |
|
|
50.83 |
ml/d |
6.48 |
15.87 |
urine volume measurement method |
|
3600.0 |
|
0 |
|
|
|
104029 |
2886 |
LH/Mav |
plasma creatinine level |
streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood creatinine amount |
male |
112 days
| 9 |
|
|
0.54 |
mg/dl |
0.01 |
0.03 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102677 |
2703 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 8 |
|
|
24.4 |
mg/g |
0.4 |
1.13 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102682 |
2703 |
LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112 days
| 7 |
|
|
12.5 |
mg/100g |
0.5 |
1.32 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102691 |
2703 |
LL/Mav |
urine total protein excretion rate |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
total urine protein amount |
male |
56 days
| 18 |
|
|
32.0 |
mg/d |
2.0 |
8.49 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
102711 |
2721 |
LH/Mav |
timed urine volume |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
56 days
| 14 |
|
|
10.6 |
ml/d |
0.3 |
1.12 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
102709 |
2721 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156 days
| 10 |
|
|
534.6 |
mg/dl |
22.5 |
71.15 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
99106 |
2219 |
WKY |
body weight |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
body mass |
male |
156 days
| 10 |
|
|
287.24 |
g |
20.18 |
63.81 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
99111 |
2219 |
MHS |
mean arterial blood pressure |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
arterial blood pressure trait |
male |
213 days
| 6 |
|
|
127.2 |
mmHg |
3.5 |
8.57 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
0.0 |
|
0 |
|
|
|
104023 |
2886 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (0.5 mg/kg/d) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
364 days
| 6 |
|
|
158.59 |
null |
4.58 |
11.22 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
308 |
days |
|
|
100776 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
364 days
| 6 |
|
|
182.12 |
null |
13.44 |
32.92 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
308 |
days |
|
|
100777 |
2522 |
SD |
glomerular filtration rate to body weight ratio |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.67 |
ml/min/100g |
0.03 |
0.08 |
inulin analysis by thiourea-resorcinol assay |
|
0.0 |
stz |
224 |
days |
|
|
99926 |
2358 |
SD |
effective renal plasma flow |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
|
2.31 |
ml/min/100g |
0.08 |
0.22 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
stz |
224 |
days |
|
|
99929 |
2358 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 8 |
|
|
233.0 |
g |
5.0 |
14.14 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
99938 |
2378 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 6 |
|
|
229.0 |
g |
6.0 |
14.7 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
99939 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 8 |
|
|
350.0 |
mg/dl |
18.0 |
50.91 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
99941 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 8 |
|
|
352.0 |
mg/dl |
17.0 |
48.08 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
99942 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.23 |
null |
0.12 |
0.34 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99957 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 6 |
|
|
8.8 |
mmHg/ml/min |
0.5 |
1.22 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99964 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 8 |
|
|
41.62 |
ml/d |
9.07 |
25.66 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
99968 |
2378 |
Crl:SD |
kidney glomerulus volume |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then enalapril (15 mg/l) (for 63 days) and anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
kidney glomerulus morphology trait |
male |
427 days
| 6 |
|
|
2.37 |
x 10E6 um3 |
0.15 |
0.37 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
371 |
days |
|
|
100787 |
2522 |
MHS |
artery tunica media width to artery inner diameter ratio |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
0.93 |
null |
|
0.46 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104137 |
2907 |
MNS |
blood hemoglobin A1c level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood hemoglobin amount |
male |
252 days
| 11 |
|
|
15.5 |
% |
0.63 |
2.1 |
affinity chromatography |
tail vein |
0.0 |
|
0 |
|
affinity chromatography (MMO:0000845) |
|
104095 |
2907 |
SBH/Ygl |
heart weight |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart mass |
male |
98 days
| 7 |
|
|
1.03 |
g |
0.08 |
0.2 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
106711 |
3038 |
SBH/Ygl |
heart left ventricle end-diastolic diameter to body weight ratio |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
|
2.6 |
mm/kg |
0.2 |
0.53 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
106718 |
3038 |
SBH/Ygl |
heart left ventricle end-diastolic diameter to body weight ratio |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
|
2.7 |
mm/kg |
0.1 |
0.26 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
106719 |
3038 |
SBH/Ygl |
heart left ventricle end-systolic diameter to body weight ratio |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-systolic diameter |
male |
98 days
| 7 |
|
|
0.99 |
mm/kg |
0.1 |
0.26 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
106722 |
3038 |
SBH/Ygl |
blood glucose level |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
blood glucose amount |
male |
98 days
| 7 |
|
|
361.8 |
mg/dl |
32.4 |
85.72 |
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
106695 |
3038 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 17 |
|
|
9.9 |
mg/g |
0.7 |
2.89 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
107456 |
2378 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 16 |
|
|
8.3 |
mg/g |
0.2 |
0.8 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
107459 |
2378 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 16 |
|
|
11.7 |
x 10E3 um2 |
2.9 |
11.6 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
|
107514 |
2378 |
MNS |
timed urine volume |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
urine output |
male |
213 days
| 9 |
|
|
56.88 |
ml/d |
11.23 |
33.7 |
urine volume measurement method |
|
3600.0 |
|
0 |
|
|
|
104030 |
2886 |
LH/Mav |
plasma triglyceride level |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood triglyceride amount |
male |
112 days
| 9 |
|
|
1.96 |
mmol/l |
0.2 |
0.6 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
102670 |
2703 |
LH/Mav |
plasma creatinine level |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood creatinine amount |
male |
112 days
| 8 |
|
|
0.61 |
mg/dl |
0.05 |
0.14 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102676 |
2703 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 11 |
|
|
19.9 |
mg/g |
0.5 |
1.66 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102684 |
2703 |
LH/Mav |
urine total protein excretion rate |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
total urine protein amount |
male |
56 days
| 14 |
|
|
127.0 |
mg/d |
7.0 |
26.19 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
102713 |
2721 |
SD |
systolic blood pressure |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
|
152.0 |
mmHg |
1.06 |
3.0 |
tail cuff plethysmography |
|
0.0 |
stz |
154 |
days |
|
|
99899 |
2358 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
|
9.2 |
mmHg/ml/min |
0.4 |
1.13 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99963 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
|
9.0 |
mmHg/ml/min |
0.4 |
1.13 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99961 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 6 |
|
|
44.93 |
ml/d |
8.78 |
21.52 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
99969 |
2378 |
MHS |
glomerular filtration rate |
streptozotocin (50 mg/kg) (for 147 days) and insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
glomerular filtration trait |
male |
213 days
| 6 |
|
|
0.0 |
ml/min |
0.0 |
0.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104027 |
2886 |
LH/Mav |
body weight |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
body mass |
male |
56 days
| 14 |
|
|
248.0 |
g |
4.0 |
14.97 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
102701 |
2721 |
LH/Mav |
blood glucose level |
streptozotocin (75 mg/kg) then fasting (for 16 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56 days
| 14 |
|
|
72.0 |
mg/dl |
1.0 |
3.74 |
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
102717 |
2721 |
LL/Mav |
urine albumin excretion rate |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine albumin amount |
male |
112 days
| 18 |
|
|
3.6 |
mg/d |
0.2 |
0.85 |
urine albumin analysis |
|
0.0 |
|
0 |
|
|
|
102739 |
2721 |
LH/Mav |
urine albumin excretion rate |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine albumin amount |
male |
112 days
| 14 |
|
|
35.6 |
mg/d |
1.8 |
6.73 |
urine albumin analysis |
|
0.0 |
|
0 |
|
|
|
102741 |
2721 |
LL/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
heart left ventricle mass |
male |
112 days
| 18 |
|
|
1.93 |
mg/g |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102767 |
2721 |
LL/Mav |
creatinine clearance |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
glomerular filtration trait |
male |
112 days
| 18 |
|
|
1.35 |
ml/min |
0.05 |
0.21 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102775 |
2721 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 17 |
|
|
45.6 |
% |
0.3 |
1.24 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
99977 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 16 |
|
|
0.66 |
ml/min/100g |
0.02 |
0.09 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99983 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 16 |
|
|
3.19 |
ml/min/100g |
0.13 |
0.52 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99994 |
2378 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 17 |
|
|
16.7 |
mmHg/ml/min |
1.4 |
5.77 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99996 |
2378 |
LH/Mav |
blood glucose level |
streptozotocin (75 mg/kg) then fasting (for 16 hours) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood glucose amount |
male |
49 days-56 days |
37 |
|
|
70.0 |
mg/dl |
1.0 |
6.08 |
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
102658 |
2703 |
LH/Mav |
plasma triglyceride level |
streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood triglyceride amount |
male |
112 days
| 11 |
|
|
1.5 |
mmol/l |
0.12 |
0.4 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
102672 |
2703 |
LH/Mav |
plasma creatinine level |
streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood creatinine amount |
male |
112 days
| 11 |
|
|
0.54 |
mg/dl |
0.01 |
0.03 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102678 |
2703 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 9 |
|
|
23.8 |
mg/g |
0.8 |
2.4 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102683 |
2703 |
LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112 days
| 8 |
|
|
13.5 |
mg/100g |
0.5 |
1.41 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102688 |
2703 |
LH/Mav |
both kidneys wet weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
kidney mass |
male |
112 days
| 8 |
|
|
6.95 |
g/kg |
0.23 |
0.65 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102694 |
2703 |
LH/Mav |
aorta weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
aorta mass |
male |
112 days
| 9 |
|
|
12.3 |
mg/100g |
0.4 |
1.2 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102689 |
2703 |
LH/Mav |
systolic blood pressure |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
arterial blood pressure trait |
male |
56 days
| 14 |
mean of 3 samples of undefined duration |
serial mean |
148.0 |
mmHg |
4.0 |
14.97 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
102705 |
2721 |
LL/Mav |
timed urine volume |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
56 days
| 18 |
|
|
8.9 |
ml/d |
0.3 |
1.27 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
102707 |
2721 |
LH/Mav |
body weight |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
body mass |
male |
49 days-56 days |
37 |
|
|
233.0 |
g |
4.0 |
24.33 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
102643 |
2703 |
LH/Mav |
urine creatinine excretion rate |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
urine creatinine amount |
male |
49 days-56 days |
37 |
|
|
8.6 |
mg/d |
0.3 |
1.82 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102652 |
2703 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156 days
| 10 |
|
|
520.92 |
mg/dl |
28.8 |
91.07 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
99102 |
2219 |
WKY |
timed urine volume |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156 days
| 10 |
|
|
58.33 |
ml/d |
8.45 |
26.72 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
99123 |
2219 |
SD |
body weight |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
|
|
563.0 |
g |
12.37 |
35.0 |
body weighing method |
|
0.0 |
stz |
154 |
days |
|
|
99891 |
2358 |
SD |
body weight |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
|
|
588.0 |
g |
27.58 |
78.0 |
body weighing method |
|
0.0 |
stz |
224 |
days |
|
|
99914 |
2358 |
SD |
left kidney wet weight |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney mass |
male |
0 days
| 8 |
|
|
2.18 |
g |
0.05 |
0.14 |
post excision weight measurement |
|
0.0 |
stz |
224 |
days |
|
|
99917 |
2358 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 8 |
|
|
215.0 |
g |
10.0 |
28.28 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
99936 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.52 |
ml/min/100g |
0.03 |
0.07 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99947 |
2378 |
Crl:SD |
kidney glomerulus volume |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then enalapril (15 mg/l) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
kidney glomerulus morphology trait |
male |
427 days
| 6 |
|
|
2.4 |
x 10E6 um3 |
0.11 |
0.27 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
371 |
days |
|
|
100786 |
2522 |
Crl:SD |
kidney glomerulus volume |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
kidney glomerulus morphology trait |
male |
427 days
| 6 |
|
|
3.14 |
x 10E6 um3 |
0.19 |
0.47 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
371 |
days |
|
|
100784 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
|
|
158.33 |
null |
4.59 |
11.24 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
371 |
days |
|
|
100789 |
2522 |
MNS |
artery tunica media width to artery inner diameter ratio |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
0.64 |
null |
|
0.28 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104135 |
2907 |
MNS |
artery tunica media to artery total diameter ratio |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
26.8 |
% |
|
5.3 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104143 |
2907 |
MNS |
body weight |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
252 days
| 12 |
|
|
345.0 |
g |
15.01 |
52.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104069 |
2907 |
MNS |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252 days
| 11 |
|
|
473.4 |
mg/dl |
13.03 |
43.2 |
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
104082 |
2907 |
MHS |
mean arterial blood pressure |
streptozotocin (55 ml/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
arterial blood pressure trait |
male |
252 days
| 6 |
|
|
139.8 |
mmHg |
1.84 |
4.5 |
vascular fluid filled catheter |
trunk of common carotid artery |
0.0 |
|
0 |
|
|
|
104109 |
2907 |
MNS |
mean arterial blood pressure |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
arterial blood pressure trait |
male |
252 days
| 6 |
|
|
94.4 |
mmHg |
0.98 |
2.4 |
vascular fluid filled catheter |
trunk of common carotid artery |
0.0 |
|
0 |
|
|
|
104107 |
2907 |
MHS |
mean arterial blood pressure |
streptozotocin (55 ml/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
arterial blood pressure trait |
male |
168 days
| 6 |
|
|
138.1 |
mmHg |
4.78 |
11.7 |
vascular fluid filled catheter |
trunk of common carotid artery |
0.0 |
|
0 |
|
|
|
104105 |
2907 |
MHS |
glomerular filtration rate |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
glomerular filtration trait |
male |
126 days
| 6 |
|
|
3.43 |
ml/min |
0.13 |
0.31 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104117 |
2907 |
MNS |
renal plasma flow (inulin) |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney plasma flow trait |
male |
126 days
| 6 |
|
|
13.39 |
ml/min |
0.53 |
1.3 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104123 |
2907 |
MHS |
renal vascular resistance |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
renal blood flow trait |
male |
126 days
| 6 |
|
|
6.2 |
mmHg/ml/min |
0.35 |
0.86 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104129 |
2907 |
SBH/Ygl |
body weight |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
body mass |
male |
98 days
| 7 |
|
|
216.0 |
g |
13.0 |
34.39 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
106703 |
3038 |
SBH/Ygl |
food intake weight to body weight ratio |
controlled sodium chloride content diet (0.65 %) (for 84 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 28 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
eating behavior trait |
male |
84 days
| 7 |
|
|
18.04 |
g/d/100g |
0.82 |
2.17 |
food intake measuring method |
|
0.0 |
|
0 |
|
|
|
106706 |
3038 |
SBH/Ygl |
heart left ventricle fractional shortening |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
|
61.0 |
% |
4.0 |
10.58 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
106714 |
3038 |
SBH/Ygl |
heart left ventricle end-systolic diameter to body weight ratio |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-systolic diameter |
male |
98 days
| 7 |
|
|
0.95 |
mm/kg |
0.09 |
0.24 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
106723 |
3038 |
SBH/Ygl |
blood glucose level |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
blood glucose amount |
male |
98 days
| 7 |
|
|
383.4 |
mg/dl |
21.6 |
57.15 |
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
0 |
|
|
|
106694 |
3038 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 17 |
|
|
256.0 |
g |
5.0 |
20.62 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
107446 |
2378 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 16 |
|
|
3.1 |
g/kg |
0.1 |
0.4 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
107453 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 17 |
|
|
19.3 |
x 10E3 um2 |
4.8 |
19.79 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
107461 |
2378 |
WKY |
left kidney wet weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney mass |
male |
0 days
| 17 |
|
|
8.2 |
mg/g |
0.2 |
0.82 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
107457 |
2378 |
WKY |
kidney glomerular tuft surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 17 |
|
|
13.2 |
x 10E3 um2 |
3.3 |
13.61 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
|
107511 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 16 |
|
|
15.8 |
x 10E3 um2 |
4.0 |
16.0 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
107463 |
2378 |
SD |
effective renal plasma flow |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
|
2.31 |
ml/min/100g |
0.06 |
0.16 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
stz |
154 |
days |
|
|
99906 |
2358 |
WKY |
renal vascular resistance |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
arterial blood pressure trait |
male |
0 days
| 17 |
|
|
6.6 |
mmHg/ml/min |
0.3 |
1.24 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99997 |
2378 |
LH/Mav |
blood glucose level |
streptozotocin (75 mg/kg) then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood glucose amount |
male |
49 days-56 days |
37 |
|
|
300.0 |
mg/dl |
8.0 |
48.66 |
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
102661 |
2703 |
LH/Mav |
plasma total cholesterol level |
streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood cholesterol amount |
male |
112 days
| 10 |
|
|
83.78 |
mg/dl |
6.56 |
20.76 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
102665 |
2703 |
LL/Mav |
systolic blood pressure |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
arterial blood pressure trait |
male |
112 days
| 18 |
mean of 3 samples of undefined duration |
serial mean |
123.0 |
mmHg |
2.0 |
8.49 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
102727 |
2721 |
LH/Mav |
blood glucose level |
streptozotocin (75 mg/kg) then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56 days
| 14 |
|
|
358.0 |
mg/dl |
11.0 |
41.16 |
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
102721 |
2721 |
LL/Mav |
blood glucose level |
streptozotocin (100 mg/kg) then fasting (for 16 hours) then glucose (2 g/kg) (for 1 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56 days
| 18 |
|
|
337.0 |
mg/dl |
10.0 |
42.43 |
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
102719 |
2721 |
LH/Mav |
timed urine volume |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine output |
male |
112 days
| 14 |
|
|
11.9 |
ml/d |
0.5 |
1.87 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
102733 |
2721 |
LL/Mav |
urine total protein excretion rate |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
total urine protein amount |
male |
112 days
| 18 |
|
|
35.0 |
mg/d |
2.0 |
8.49 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
102735 |
2721 |
LL/Mav |
urine albumin level to urine total protein level ratio |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine albumin amount |
male |
112 days
| 18 |
|
|
10.4 |
% |
0.4 |
1.7 |
urine albumin analysis |
|
0.0 |
|
0 |
|
|
|
102743 |
2721 |
SD |
effective renal plasma flow |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney plasma flow trait |
male |
0 days
| 8 |
|
|
2.28 |
ml/min/100g |
0.05 |
0.15 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
stz |
154 |
days |
|
|
99905 |
2358 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 17 |
|
|
44.8 |
% |
0.6 |
2.47 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
99976 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 16 |
|
|
0.21 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99989 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 16 |
|
|
45.5 |
ml/d |
5.04 |
20.16 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
100003 |
2378 |
LH/Mav |
plasma total cholesterol level |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood cholesterol amount |
male |
112 days
| 9 |
|
|
82.24 |
mg/dl |
6.95 |
20.85 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
102664 |
2703 |
LL/Mav |
blood glucose level |
streptozotocin (100 mg/kg) then fasting (for 16 hours) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood glucose amount |
male |
56 days
| 18 |
|
|
71.0 |
mg/dl |
1.0 |
4.24 |
blood glucose analysis |
|
0.0 |
|
0 |
|
|
|
102715 |
2721 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156 days
| 10 |
|
|
537.12 |
mg/dl |
28.98 |
91.64 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
99105 |
2219 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156 days
| 10 |
|
|
533.7 |
mg/dl |
25.56 |
80.83 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
99103 |
2219 |
WKY |
body weight |
streptozotocin (60 mg/kg) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
body mass |
male |
156 days
| 10 |
|
|
259.65 |
g |
18.96 |
59.96 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
99108 |
2219 |
WKY |
body weight |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
body mass |
male |
156 days
| 10 |
|
|
286.6 |
g |
21.95 |
69.41 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
99112 |
2219 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then enalapril (15 mg/l) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
364 days
| 6 |
|
|
201.08 |
null |
15.0 |
36.74 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
308 |
days |
|
|
100778 |
2522 |
SD |
left kidney wet weight |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney mass |
male |
0 days
| 8 |
|
|
2.14 |
g |
0.04 |
0.12 |
post excision weight measurement |
|
0.0 |
stz |
224 |
days |
|
|
99918 |
2358 |
SD |
blood glucose level |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0 days
| 8 |
|
|
358.0 |
mg/dl |
20.86 |
59.0 |
blood glucose analysis |
|
0.0 |
stz |
224 |
days |
|
|
99920 |
2358 |
SD |
systolic blood pressure |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
|
128.0 |
mmHg |
1.06 |
3.0 |
tail cuff plethysmography |
|
0.0 |
stz |
224 |
days |
|
|
99924 |
2358 |
SD |
glomerular filtration rate to body weight ratio |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.65 |
ml/min/100g |
0.02 |
0.06 |
inulin analysis by thiourea-resorcinol assay |
|
0.0 |
stz |
224 |
days |
|
|
99927 |
2358 |
WKY |
body weight |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 8 |
|
|
236.0 |
g |
7.0 |
19.8 |
body weighing method |
|
0.0 |
unx |
28 |
days |
|
|
99937 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.23 |
null |
0.14 |
0.4 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99958 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 8 |
|
|
23.47 |
ml/d |
1.73 |
4.89 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
99966 |
2378 |
Crl:SD |
kidney glomerulus volume |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
kidney glomerulus morphology trait |
male |
427 days
| 6 |
|
|
2.44 |
x 10E6 um3 |
0.21 |
0.51 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
371 |
days |
|
|
100785 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
|
|
178.53 |
null |
22.47 |
55.04 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
371 |
days |
|
|
100790 |
2522 |
MNS |
artery lumen to artery total diameter ratio |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
46.4 |
% |
|
10.6 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104151 |
2907 |
MHS |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252 days
| 14 |
|
|
478.8 |
mg/dl |
12.51 |
46.8 |
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
104084 |
2907 |
MNS |
blood hemoglobin A1c level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood hemoglobin amount |
male |
168 days
| 8 |
|
|
15.4 |
% |
0.53 |
1.5 |
affinity chromatography |
tail vein |
0.0 |
|
0 |
|
affinity chromatography (MMO:0000845) |
|
104091 |
2907 |
MHS |
blood hemoglobin A1c level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood hemoglobin amount |
male |
168 days
| 9 |
|
|
15.7 |
% |
0.47 |
1.4 |
affinity chromatography |
tail vein |
0.0 |
|
0 |
|
affinity chromatography (MMO:0000845) |
|
104093 |
2907 |
Crl:WI |
blood hemoglobin A1c level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood hemoglobin amount |
male |
252 days
| 14 |
|
|
15.5 |
% |
0.29 |
1.1 |
affinity chromatography |
tail vein |
0.0 |
|
0 |
|
affinity chromatography (MMO:0000845) |
|
104099 |
2907 |
MHS |
single kidney wet weight |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney mass |
male |
126 days
| 6 |
|
|
2.53 |
g |
0.22 |
0.55 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104113 |
2907 |
MNS |
artery diameter |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
25.4 |
um |
|
8.7 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104131 |
2907 |
SBH/Ygl |
food intake weight to body weight ratio |
controlled sodium chloride content diet (8 %) (for 28 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 28 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
eating behavior trait |
male |
84 days
| 7 |
|
|
15.72 |
g/d/100g |
0.7 |
1.85 |
food intake measuring method |
|
0.0 |
|
0 |
|
|
|
106707 |
3038 |
SBH/Ygl |
heart left ventricle fractional shortening |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
|
65.0 |
% |
1.0 |
2.65 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
106715 |
3038 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 17 |
|
|
274.0 |
g |
6.0 |
24.74 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
107447 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 16 |
|
|
16.4 |
x 10E3 um2 |
4.1 |
16.4 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
107464 |
2378 |
WKY |
kidney glomerular surface area |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney glomerulus size trait |
male |
0 days
| 17 |
|
|
17.0 |
x 10E3 um2 |
4.1 |
16.9 |
ex vivo light microscopy with histochemistry |
|
0.0 |
unx |
150 |
days |
|
kidney glomerulus surface area (CMO:0003488) |
107462 |
2378 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 16 |
|
|
3.1 |
g/kg |
0.1 |
0.4 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
107454 |
2378 |
MNS |
renal vascular resistance |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
renal blood flow trait |
male |
126 days
| 6 |
|
|
5.04 |
mmHg/ml/min |
0.24 |
0.59 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
|
104127 |
2907 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 17 |
|
|
324.0 |
mg/dl |
13.0 |
53.6 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
99971 |
2378 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 16 |
|
|
308.0 |
mg/dl |
15.0 |
60.0 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
99973 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 17 |
|
|
0.69 |
ml/min/100g |
0.03 |
0.13 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99982 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 16 |
|
|
3.15 |
ml/min/100g |
0.13 |
0.52 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99993 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 16 |
|
|
49.25 |
ml/d |
5.18 |
20.74 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
100004 |
2378 |
WKY |
single kidney wet weight to body weight ratio |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
kidney mass |
male |
156 days
| 10 |
|
|
4.73 |
g/kg |
0.37 |
1.17 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
99117 |
2219 |
LH/Mav |
urine protein level to urine creatinine level ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
total urine protein amount |
male |
49 days-56 days |
37 |
|
|
9.3 |
null |
0.5 |
3.04 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
102655 |
2703 |
LL/Mav |
systolic blood pressure |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
arterial blood pressure trait |
male |
56 days
| 18 |
mean of 3 samples of undefined duration |
serial mean |
124.0 |
mmHg |
3.0 |
12.73 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
102703 |
2721 |
LH/Mav |
systolic blood pressure |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
arterial blood pressure trait |
male |
49 days-56 days |
37 |
undefined |
|
145.0 |
mmHg |
2.0 |
12.17 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
102646 |
2703 |
MNS |
mean arterial blood pressure |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
arterial blood pressure trait |
male |
213 days
| 9 |
|
|
111.4 |
mmHg |
4.5 |
13.5 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
0.0 |
|
0 |
|
|
|
104024 |
2886 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 6 |
|
|
2.42 |
ml/min/100g |
0.09 |
0.22 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99954 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 6 |
|
|
0.21 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
|
99959 |
2378 |
LL/Mav |
body weight |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
body mass |
male |
112 days
| 18 |
|
|
331.0 |
g |
3.0 |
12.73 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
102723 |
2721 |
LH/Mav |
urine albumin level to urine total protein level ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine albumin amount |
male |
112 days
| 14 |
|
|
19.6 |
% |
0.7 |
2.62 |
urine albumin analysis |
|
0.0 |
|
0 |
|
|
|
102745 |
2721 |
LL/Mav |
urine creatinine excretion rate |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
urine creatinine amount |
male |
112 days
| 18 |
|
|
9.8 |
mg/d |
0.3 |
1.27 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102747 |
2721 |
LH/Mav |
plasma creatinine level |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood creatinine amount |
male |
112 days
| 14 |
|
|
0.55 |
mg/dl |
0.01 |
0.03 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
|
|
102761 |
2721 |
SD |
body weight |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
|
|
526.0 |
g |
10.25 |
29.0 |
body weighing method |
|
0.0 |
stz |
154 |
days |
|
|
99871 |
2358 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 17 |
|
|
312.0 |
mg/dl |
24.0 |
98.95 |
machine read blood glucose test strip |
|
0.0 |
unx |
168 |
days |
|
|
99972 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 17 |
|
|
0.21 |
null |
0.01 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99987 |
2378 |
MHS |
urine potassium excretion rate |
streptozotocin (50 mg/kg) (for 147 days) then insulin (2 IU/d) (for 147 days) |
Ge Y, et al., Physiol Rep. 2017 Feb;5(3). pii: 5/3/e13089. doi: 10.14814/phy2.13089. |
urine potassium amount |
male |
213 days
| 6 |
|
|
4.29 |
mEq/d |
0.53 |
1.3 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
104033 |
2886 |
LH/Mav |
plasma total cholesterol level |
streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
blood cholesterol amount |
male |
112 days
| 11 |
|
|
73.36 |
mg/dl |
4.63 |
15.37 |
blood cholesterol analysis |
|
0.0 |
|
0 |
|
|
|
102666 |
2703 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 7 |
|
|
24.2 |
mg/g |
0.3 |
0.79 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102685 |
2703 |
LH/Mav |
both kidneys wet weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
kidney mass |
male |
112 days
| 11 |
|
|
6.44 |
g/kg |
0.14 |
0.46 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102696 |
2703 |
WKY |
blood glucose level |
streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
blood glucose amount |
male |
156 days
| 10 |
|
|
523.26 |
mg/dl |
27.18 |
85.95 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
99104 |
2219 |
WKY |
single kidney wet weight to body weight ratio |
streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
kidney mass |
male |
156 days
| 10 |
|
|
4.72 |
g/kg |
0.31 |
0.98 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
99118 |
2219 |
WKY |
timed urine volume |
streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156 days
| 10 |
|
|
133.86 |
ml/d |
16.58 |
52.43 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
99121 |
2219 |
WKY |
timed urine volume |
streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 PFU) |
Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. |
urine output |
male |
156 days
| 10 |
|
|
62.68 |
ml/d |
15.67 |
49.55 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
99122 |
2219 |
SD |
blood glucose level |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0 days
| 8 |
|
|
343.0 |
mg/dl |
18.38 |
52.0 |
blood glucose analysis |
|
0.0 |
stz |
154 |
days |
|
|
99897 |
2358 |
SD |
systolic blood pressure |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
|
128.0 |
mmHg |
1.06 |
3.0 |
tail cuff plethysmography |
|
0.0 |
stz |
154 |
days |
|
|
99900 |
2358 |
Crl:SD |
kidney glomerulus volume |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then enalapril (15 mg/l) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
kidney glomerulus morphology trait |
male |
364 days
| 6 |
|
|
2.06 |
x 10E6 um3 |
0.14 |
0.34 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
308 |
days |
|
|
100774 |
2522 |
Crl:SD |
kidney glomerulus volume |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (0.5 mg/kg/d) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
kidney glomerulus morphology trait |
male |
364 days
| 6 |
|
|
3.14 |
x 10E6 um3 |
0.19 |
0.47 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
stz |
308 |
days |
|
|
100772 |
2522 |
SD |
renal filtration fraction |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.3 |
null |
0.01 |
0.03 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
stz |
154 |
days |
GFR by inulin method |
|
99911 |
2358 |
SD |
blood glucose level |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0 days
| 8 |
|
|
350.0 |
mg/dl |
19.09 |
54.0 |
blood glucose analysis |
|
0.0 |
stz |
224 |
days |
|
|
99921 |
2358 |
SD |
renal filtration fraction |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
0.29 |
null |
0.01 |
0.02 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
stz |
224 |
days |
GFR by inulin method |
|
99933 |
2358 |
WKY |
blood glucose level |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
blood glucose amount |
male |
0 days
| 6 |
|
|
367.0 |
mg/dl |
12.0 |
29.39 |
machine read blood glucose test strip |
|
0.0 |
unx |
28 |
days |
|
|
99944 |
2378 |
MHS |
artery tunica media to artery total diameter ratio |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
31.4 |
% |
|
4.7 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104145 |
2907 |
MHS |
artery inner diameter |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
10.1 |
um |
|
4.4 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104149 |
2907 |
MHS |
body weight |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
252 days
| 14 |
|
|
337.0 |
g |
12.56 |
47.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
104071 |
2907 |
MHS |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
168 days
| 9 |
|
|
462.6 |
mg/dl |
19.8 |
59.4 |
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
104080 |
2907 |
MNS |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
168 days
| 8 |
|
|
453.6 |
mg/dl |
15.91 |
45.0 |
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
104078 |
2907 |
Crl:WI |
blood glucose level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood glucose amount |
male |
252 days
| 14 |
|
|
473.4 |
mg/dl |
10.1 |
37.8 |
colorimetry |
tail vein |
0.0 |
|
0 |
|
|
|
104086 |
2907 |
MHS |
blood hemoglobin A1c level |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood hemoglobin amount |
male |
252 days
| 17 |
|
|
15.7 |
% |
0.75 |
3.1 |
affinity chromatography |
tail vein |
0.0 |
|
0 |
|
affinity chromatography (MMO:0000845) |
|
104097 |
2907 |
MNS |
single kidney wet weight |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney mass |
male |
126 days
| 6 |
|
|
3.08 |
g |
0.13 |
0.31 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
104111 |
2907 |
MNS |
renal filtration fraction |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
glomerular filtration trait |
male |
126 days
| 6 |
((A-V)/A)*100 |
|
0.31 |
null |
0.0 |
0.01 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
filtration fraction |
104119 |
2907 |
SBH/Ygl |
systolic blood pressure |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
arterial blood pressure trait |
male |
98 days
| 7 |
|
|
128.0 |
mmHg |
2.0 |
5.29 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
106698 |
3038 |
WKY |
heart weight to body weight ratio |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
heart mass |
male |
0 days
| 17 |
|
|
3.5 |
g/kg |
0.1 |
0.41 |
post excision weight measurement |
|
0.0 |
unx |
150 |
days |
|
|
107451 |
2378 |
WKY |
body weight |
unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
body mass |
male |
0 days
| 16 |
|
|
261.0 |
g |
7.0 |
28.0 |
body weighing method |
|
0.0 |
unx |
150 |
days |
|
|
107448 |
2378 |
MHS |
artery diameter |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 168 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252 days
| 0 |
|
|
26.7 |
um |
|
8.9 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
104133 |
2907 |
MHS |
renal filtration fraction |
streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days) |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
glomerular filtration trait |
male |
126 days
| 6 |
((A-V)/A)*100 |
|
0.25 |
null |
0.0 |
0.01 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
filtration fraction |
104121 |
2907 |
LH/Mav |
plasma triglyceride level |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
blood triglyceride amount |
male |
112 days
| 14 |
|
|
2.95 |
mmol/l |
0.27 |
1.01 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
102757 |
2721 |
LL/Mav |
aorta weight to body weight ratio |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
aorta mass |
male |
112 days
| 18 |
|
|
12.2 |
mg/100g |
0.3 |
1.27 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102771 |
2721 |
WKY |
hematocrit |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
erythrocyte quantity |
male |
0 days
| 16 |
|
|
45.8 |
% |
0.5 |
2.0 |
hematocrit analysis |
|
0.0 |
unx |
168 |
days |
|
|
99978 |
2378 |
WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 17 |
|
|
0.29 |
null |
0.01 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99986 |
2378 |
WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
0 days
| 16 |
|
|
0.67 |
ml/min/100g |
0.02 |
0.08 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
|
99984 |
2378 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 17 |
|
|
39.46 |
ml/d |
4.61 |
19.0 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
168 |
days |
|
|
100001 |
2378 |
SD |
blood glucose level |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
blood glucose amount |
male |
0 days
| 8 |
|
|
334.0 |
mg/dl |
19.8 |
56.0 |
blood glucose analysis |
|
0.0 |
stz |
154 |
days |
|
|
99896 |
2358 |
WKY |
timed urine volume |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
urine output |
male |
0 days
| 8 |
|
|
38.02 |
ml/d |
5.33 |
15.07 |
metabolic cage urine volume measurement method |
|
0.0 |
unx |
28 |
days |
|
|
99967 |
2378 |